Clarithromycin Dosing for Strep Throat
For adults and children with strep throat who are allergic to penicillin, give clarithromycin 250 mg orally twice daily for 10 days (adults) or 7.5 mg/kg per dose twice daily (maximum 250 mg per dose) for 10 days in children. 1
Critical Allergy Assessment First
Before prescribing clarithromycin, determine the type of penicillin allergy:
For non-immediate/non-anaphylactic penicillin reactions (delayed rash, mild reactions), first-generation cephalosporins like cephalexin are actually preferred over clarithromycin due to stronger evidence, lower resistance rates (essentially 0% vs 5-8% for macrolides), and lower cost. 1
For immediate/anaphylactic penicillin reactions (hives, angioedema, bronchospasm within 1 hour), clindamycin is preferred over clarithromycin at 300 mg three times daily for 10 days (adults) or 7 mg/kg/dose three times daily for 10 days (children, maximum 300 mg/dose) due to lower resistance rates (~1% vs 5-8%). 1
Clarithromycin should be reserved for patients with immediate penicillin allergy who cannot tolerate clindamycin or when clindamycin is unavailable. 1
Specific Dosing Regimens
Adults
Children
- 7.5 mg/kg per dose twice daily (maximum 250 mg per dose) for 10 days 1
- Available as suspension for better palatability 3
Why the Full 10-Day Course Matters
- The full 10-day course is essential to achieve maximal pharyngeal eradication of Group A Streptococcus and prevent acute rheumatic fever. 1
- Shortening the course by even a few days dramatically increases treatment failure rates and rheumatic fever risk. 1
- Do not stop antibiotics when symptoms improve at 3-4 days—complete the full course. 1
Important Resistance Considerations
- Macrolide resistance among Group A Streptococcus is 5-8% in the United States and varies geographically, with some areas experiencing much higher rates. 1
- Check local resistance patterns before prescribing—clarithromycin should not be used in regions where macrolide resistance exceeds 10%. 1
- Clindamycin resistance remains very low at approximately 1%, making it more reliable than clarithromycin when beta-lactams cannot be used. 1
Common Pitfalls to Avoid
Do not assume all penicillin-allergic patients need clarithromycin—most patients with non-immediate reactions can safely receive first-generation cephalosporins with only 0.1% cross-reactivity risk. 1
Do not prescribe shorter courses than 10 days (except azithromycin's 5-day regimen)—this increases treatment failure and rheumatic fever risk. 1
Do not ignore local resistance patterns—macrolide resistance varies geographically and can be much higher than 5-8% in some areas. 1
Do not use clarithromycin as first-line therapy—penicillin or amoxicillin remains the drug of choice for non-allergic patients due to proven efficacy, narrow spectrum, safety, and low cost. 4
Evidence Supporting Clarithromycin
Research shows clarithromycin achieves 94% GABHS eradication rates compared to 78% with penicillin V, though this may reflect differences in compliance rather than superior efficacy. 5
A head-to-head comparison found 10 days of clarithromycin (250 mg twice daily) more effective than 5 days of azithromycin in eradicating Group A Streptococcus (91% vs 82%, p=0.012). 6
Clarithromycin offers lower rates of gastrointestinal side effects compared to erythromycin and more convenient twice-daily dosing. 3